Literature DB >> 6218840

Inhibition by nojirimycin and 1-deoxynojirimycin of microsomal glucosidases from calf liver acting on the glycoprotein oligosaccharides Glc1-3Man9GlcNAc2.

H Hettkamp, E Bause, G Legler.   

Abstract

Particulate membrane fractions from calf liver catalyze the release of glucose from GlcNAc2-Man9-Glc1-3-oligosaccharides. Maximal oligosaccharide-glucosidase activity was obtained at pH 6.2 and a detergent concentration of 0.5% Triton X-100. This activity could be distinguished from non-specific alpha-glucosidase activity on the basis of different pH-dependence and lack of activation by detergent. The relative rates for the hydrolysis of the Glc3-, Glc2-, and Glc1-oligosaccharide, estimated from the initial velocity, was 1:12:3. There is no significant difference in the enzyme activity towards free, peptide-bound, or lipid-linked oligosaccharide. Nojirimycin and 1-deoxynojirimycin were strong inhibitors of microsomal oligosaccharide-glucosidases. Hydrolysis of Glc3-oligosaccharide was inhibited by 50% at concentrations of 0.16 mM and 2 microM, respectively. Hydrolysis of the Glc2- and Glc1-oligosaccharide was inhibited to a somewhat lower extent, suggesting the presence of at least two glucosidases, one acting on Glc3- and one acting on Glc1- and Glc2-oligosaccharide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218840     DOI: 10.1007/bf01114896

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  12 in total

1.  Synthesis, Processing, and Function of N-glycans in N-glycoproteins.

Authors:  Erhard Bieberich
Journal:  Adv Neurobiol       Date:  2014

2.  Glycoprotein processing and glycoprotein processing inhibitors.

Authors:  A D Elbein
Journal:  Plant Physiol       Date:  1988-06       Impact factor: 8.340

3.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency.

Authors:  G J Gerwig; E Bause; L K Nuytinck; J F Vliegenthart; W Breuer; J P Kamerling; M F Espeel; J J Martin; N W Chan; G A Dacremont
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

4.  Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.

Authors:  E J Nichols; R Manger; S Hakomori; A Herscovics; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

5.  Abnormal processing of the modified oligosaccharide side chains of phytohemagglutinin in the presence of swainsonine and deoxynojirimycin.

Authors:  M J Chrispeels; A Vitale
Journal:  Plant Physiol       Date:  1985-08       Impact factor: 8.340

Review 6.  GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.

Authors:  Roberto De Masi; Stefania Orlando
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 7.  Synthesis, Processing, and Function of N-Glycans in N-Glycoproteins.

Authors:  Erhard Bieberich
Journal:  Adv Neurobiol       Date:  2023

8.  Chemical modification of Penicillium 1,2-alpha-D-mannosidase by water-soluble carbodi-imide: identification of a catalytically important aspartic acid residue.

Authors:  T Yoshida; K Maeda; M Kobayashi; E Ichishima
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

9.  Inhibition of N-linked oligosaccharide trimming does not interfere with surface expression of certain integral membrane proteins.

Authors:  B Burke; K Matlin; E Bause; G Legler; N Peyrieras; H Ploegh
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Effects of the glucosidase inhibitors nojirimycin and deoxynojirimycin on the biosynthesis of membrane and secretory glycoproteins.

Authors:  N Peyrieras; E Bause; G Legler; R Vasilov; L Claesson; P Peterson; H Ploegh
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.